Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria

Clinical trial NCT00907374 · COMPLETED

Trial details

NCT number: NCT00907374
Sponsor: Charles Drew University of Medicine and Science
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Microalbuminuria

Start date: 2005-07-01
Primary completion: 2009-04-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.